Evidence map›Paper›PMID 41415461›Full record

ArticlebioRxiv : the preprint server for biology2025

Human

Sydney T Honold, Kathleen Norris, Jordan N May, Elizabeth J Donald, Tyler M Shadid, Megan Kempher, Gillian A Lang, Jessica M Reel, Maureen A Cox, Jason Larabee and 3 more

Abstract readPreprint
PubMed Full text at PMC Publisher
In one paragraph

Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Sydney T HonoldDepartment of Microbiology and Immunology, University of Oklahoma Health Sciences, 940 Stanton L. Young Blvd., Oklahoma City, OK73104, United States.
Kathleen NorrisArthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, OK, USA.
Jordan N MayDepartment of Microbiology and Immunology, University of Oklahoma Health Sciences, 940 Stanton L. Young Blvd., Oklahoma City, OK73104, United States.
Elizabeth J DonaldDepartment of Microbiology and Immunology, University of Oklahoma Health Sciences, 940 Stanton L. Young Blvd., Oklahoma City, OK73104, United States.
Tyler M ShadidDepartment of Microbiology and Immunology, University of Oklahoma Health Sciences, 940 Stanton L. Young Blvd., Oklahoma City, OK73104, United States.
Megan KempherDepartment of Microbiology and Immunology, University of Oklahoma Health Sciences, 940 Stanton L. Young Blvd., Oklahoma City, OK73104, United States.
Gillian A LangDepartment of Microbiology and Immunology, University of Oklahoma Health Sciences, 940 Stanton L. Young Blvd., Oklahoma City, OK73104, United States.
Jessica M ReelDepartment of Microbiology and Immunology, University of Oklahoma Health Sciences, 940 Stanton L. Young Blvd., Oklahoma City, OK73104, United States.
Maureen A CoxDepartment of Microbiology and Immunology, University of Oklahoma Health Sciences, 940 Stanton L. Young Blvd., Oklahoma City, OK73104, United States.
Jason LarabeeDepartment of Microbiology and Immunology, University of Oklahoma Health Sciences, 940 Stanton L. Young Blvd., Oklahoma City, OK73104, United States.
Jimmy D BallardDepartment of Microbiology and Immunology, University of Oklahoma Health Sciences, 940 Stanton L. Young Blvd., Oklahoma City, OK73104, United States.
Kenneth SmithArthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, OK, USA.
Mark L LangDepartment of Microbiology and Immunology, University of Oklahoma Health Sciences, 940 Stanton L. Young Blvd., Oklahoma City, OK73104, United States.ORCID 0000-0002-5137-0576

Funding

Tracking and Evaluation CoreU54GM104938 · NIGMS · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI JUDITH A JAMES · 2013 to 2026
$68.2M
Oklahoma C. difficile U19 Challenge CoreU19AI174994 · NIAID · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI Jimmy D. Ballard · 2023 to 2026
$6.6M
Targeting chondroitin sulfate proteoglycan 4 (CSPG4) expression as a Clostridioides difficile therapeuticR01AI185203 · NIAID · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI Jason Larabee · 2024 to 2026
$1.1M
NIAID NIH HHS R01 AI185203NIAID NIH HHS U19 AI174994NIGMS NIH HHS U54 GM104938
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

antibody repertoireC. difficilememory B cellsmonoclonal antibody

Identifiers

PMID41415461
PMCPMC12710964

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.